This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: St. Jude Children's Research Hospital. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Dario Aa Vignali: Innovator in Immunology
Introduction
Dario Aa Vignali is a prominent inventor based in Germantown, TN (US). He has made significant contributions to the field of immunology, particularly through his research and innovations related to Interleukin 35 (IL-35).
Latest Patents
Dario Aa Vignali holds a patent for a polynucleotide encoding the IL-35 receptor. This receptor comprises a heterodimeric complex of the Interleukin 12Rβ2 receptor and the gp130 receptor. His patent includes various compositions that comprise the IL-35R complex, along with polynucleotides encoding the same. Additionally, it provides kits and methods for the detection of the IL-35R complex. The patent also outlines methods for modulating the activity of IL-35R and effector T cell functions using various IL-35R antagonists and agonists. Furthermore, it describes methods for screening IL-35R binding agents and modulating agents, along with various treatment methods.
Career Highlights
Dario Aa Vignali is affiliated with St. Jude Children's Research Hospital, where he continues to advance his research in immunology. His work has been instrumental in understanding the role of IL-35 in immune responses and potential therapeutic applications.
Collaborations
Dario collaborates with Lauren Collison, contributing to the innovative research environment at St. Jude Children's Research Hospital.
Conclusion
Dario Aa Vignali's contributions to immunology through his patent on the IL-35 receptor highlight his role as an influential inventor in the field. His ongoing research continues to pave the way for advancements in immunotherapy and treatment methodologies.